Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 60, Issue 2, 2011, Pages 284-291

  Zimering, Mark B ^a,b   Anderson, Robert J ^c,d   Ge, Ling ^c   Moritz, Thomas E ^c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEMOGLOBIN A1C;

ADULT; AMPUTATION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE DURATION; DISEASE MARKER; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOREACTIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; TRIGLYCERIDES;

EID: 78751646335     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.02.003     Document Type: Article

References (39)

1. Morbidity Mortality Weekly Report. 2001. Mortality from coronary heart disease and acute myocardial infarction-United States 1998;50:90-3.
2. Stamler J., Vaccaro O., Neaton J., Wentworth D. for the Multiple Risk Factor Intervention Trial Research Group Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444 (Pubitemid 23046633)
3. Folsom A.R., Chambless L.E., Duncan B.B., Gilbert A.C., Pankow J.S. and the Atherosclerosis Risk in Communities Study Investigators Prediction of coronary heart disease in middle-aged adults with diabetes Diabetes Care 26 2003 2777 2784
4. Abraira C., Duckworth W., McCarren M., Emanuele N., Arca D., and Reda D. Design of the cooperative study of glycemic control and complications in diabetes mellitus type 2 J Diab and Compl 17 2003 314 322
5. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., and Reaven P.D. Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139 Erratum in: N Engl J Med. 2009 Sep 3;361(10):1024-5. N Engl J Med. 2009 Sep 3;361(10):1028
6. Gospodarowicz D., Ferrara N., Schweigerer L., and Neufeld G. Structural characterization and biological functions of fibroblast growth factor Endocr Rev 8 1987 95 114
7. Sato Y., Hamanaka R., Ono J., Kuwano M., Rifkin D.B., and Takaki R. The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF Biochem Biophys Res Commun 174 1991 1260 1266
8. Lindner V., and Reidy M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor Proc Natl Acad Sci USA 88 1991 3739 3743
9. Esch F., Baird A., Ling N., Ueno N., Hill F., and Denoroy L. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF Proc Nat Acad Sci (USA) 19 1985 6507 6511
10. Zimering M.B., and Eng J. Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria J Clin Endocrinol Metab 81 1996 4446 4452
11. Hasdai D., Barak V., Leibovitz E., Herz I., Sclarovsky S., and Eldar M. Serum basic fibroblast growth factor levels in patients with ischemic heart disease Int J Cardiol 59 1997 133 138
12. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., and Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis Diabetologia 32 1989 219 226
13. Valmadrid C.T., Klein R., Moss S.E., and Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus Arch Intern Med 160 2000 1093 1100
14. Zimering M.B., Anderson R.J., Luo P., and Moritz T.E. Investigators for the Veterans Affairs Diabetes Trial. Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor-1 concentration in adults from the Veterans Affairs Diabetes Trial Metabolism 57 2008 1563 1569
15. Zimering M.B. Effect of intravenous bisphosphonates on release of basic fibroblast growth factor in serum of patients with cancer-associated hypercalcemia Life Sci 70 2002 1 14
16. Larsson A., Skoldenberg E., and Ericson H. Serum and plasma levels of FGF-2 and VEGF in healthy blood donors Angiogenesis 5 2002 107 110
17. Schweigerer L., Neufeld G., Friedman J., Abraham J.A., Fiddes J.C., and Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth Nature 325 1987 257 259
18. Dirix L.Y., Vermeulen P.B., Pawinski A., Prové A., Benoy I., and De Pooter C. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients Br J Cancer 76 1997 238 243
19. Ray P.E., Liu X.H., Xu L., and Rakusan T. Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome Pediatr Nephrol 13 1999 586 593
20. Hughes S.E., Crossman D., and Hall P.A. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries Cardiovasc Res 27 1993 1214 1219
21. Mydlo J.H., Kral J.G., and Macchia R.J. Differences in prostate and adipose tissue basic fibroblast growth factor: analysis of preliminary results Urology 50 1997 472 478
22. Teichert-Kuliszewsak K., Hamilton B.S., Deitel M., and Roncari D.A. Augmented production of heparin-binding mitogenic proteins by preadipocytes from massively obese persons J Clin Invest 90 1992 1226 1231
23. Liuzzo J.P., Petanceska S.S., Moscatelli D., and Devi L.A. 1999. Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions Mol Med 5 1999 320 333
24. Samaniego F., Markham P.D., Gendelman R., Gallo R.C., and Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice J Immunol 158 1997 1887 1894
25. Kurata A., Nishizawa H., Kihara S., Maeda N., Sonoda M., and Okada T. Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation Kidney Int 70 2006 1717 1724
26. Itoh H., Mukoyama M., Pratt R., Gibbons G., and Dzau V. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II J Clin Invest 91 1993 2268 2274
27. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction and imbalanced coagulation in development of diabetes and its complications J Clin Endocrinol Metab 94 2009 3171 3182
28. Sharma K., and Ziyadeh F.N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator Diabetes 44 1995 1139 1146
29. Larsson A., and Hansson L.O. High sensitivity CRP and serum amyloid A as expressions of low grade inflammation do not correlate with bFGF or VEGF Ups J Med Sci 108 2003 51 59
30. Kraemer R., Pomerantz K.B., Joseph-Silverstein J., and Hajjar D.P. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesterol ester enrichment and 25-hydroxycholesterol J Biol Chem 268 1993 8040 8045
31. Cucina A., Scavo M.P., Muzzioli L., Coluccia P., Ceccarini S., and Fuso A. High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells Atherosclerosis 189 2006 303 309
32. Gosgnach W., Challah M., Coulet F., Michel J.B., and Battle T. Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF Cardiovasc Res 45 2000 486 492
33. Hughes S.E. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries Cardiovasc Res 32 1996 557 569
34. Kaneko T., Fujii S., Matsumoto A., Goto D., Ishimori N., and Watano K. Induction of plasminogen activator inhibitor-1 in endothelial cells by basic fibroblast growth factor and its modulation by fibric acid Arterioscler Thromb Vasc Biol 22 2002 855 860
35. Thogersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., and Huhtasaari F. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor Circulation 98 1998 2241 2247
36. Pickering J.G., Ford C.M., Tang B., and Chow L.H. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity Arterioscler Thromb Vasc Biol 17 1997 475 482
37. Okamura K., Sato Y., Matsuda T., Hamanaka R., Ono M., and Kohno K. Endogenous basic fibroblast growth factor-dependent induction of collagenase and interleukin-6 in tumor necrosis factor-treated human microvascular endothelial cells J Biol Chem 266 1991 19162 19165
38. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
39. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., and Engelgau M.M. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002 Diabetes Care 29 2006 1263 1268